OKYO Pharma Ltd — Form 4/A
Filed August 7, 2026 · analyzed by the Insider Agent
4/A
▲ Likely positive
significance 52/100
What the filing says
Director CERRONE GABRIELE M (OKYO) bought 23K shares (~$33K) on the open market (0.2% of holdings). Open-market insider purchase — historically a bullish signal.
Why this rating
Open-market insider purchase — historically a bullish signal.
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.